Headway in Alzheimer’s disease care: New guidance provides recommendations for use of anti-amyloid monoclonal antibodies
Headway in Alzheimer’s disease care: New guidance provides recommendations for use of anti-amyloid monoclonal antibodies The new guidelines for the use of monoclonal antibodies (MABs) published in neurodegenerative diseases, serve as exemplary clinical recommendations for…
